PACIRA PHARMACEUTICALS, INC.
Parsippany, NJ and Shanghai, China (June 20, 2018)
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) and Nuance Biotech Co. Ltd (Nuance) today announced that they have entered into an agreement with Nuance, a China based specialty pharmaceutical company, to advance the development and commercialization of EXPAREL® (bupivacaine liposome injectable suspension) in China. EXPAREL is a non-opioid option for achieving long-lasting pain control after surgery via infiltration into the surgical site or administration as an interscalene brachial plexus nerve block. “We are thrilled to expand the commercial opportunity for EXPAREL to China with a strong locally-based partner,” said Dave Stack, chairman... (Read More)